(7.) Ogilvie IM, Newton N, Welner SA, Cowell W, Lip GYH
. Underuse of oral anticoagulants in atrial fibrillation: a systematic review.
[29.] Pisters R, Lane DA, Nieuwlaat R, de Vos CB, Crijns HJGM, Lip GYH
. A novel user-friendly score (HASBLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: The Euro Heart Survey.
Turpie GGA, Chin BSP, Lip GYH
. Venous thrombo-embolism: pathophysiology, clinical features, and prevention.
. Refining Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation Using a Novel Risk Factor-Based Approach; The Euro Heart Survey on Atrial Fibrillation; CHEST J.
(9.) Chin BSP, Conway DSG, Chung NAY, Blann AD, Gibbs CR, Lip GYH
. Interleukin- 6, tissue factor and von Willebrand factor in acute decompensated heart failure: Relationship to treatment and prognosis.
Shantsila E, Watson T, Lip GYH
. Laboratory investigations of platelets.
[3.] Kamath S and Lip GYH
. Fibrinogen: Biochemistry, epidemiology and determinants.
(3.) Watson RDS, Gibbs CR, Lip GYH
. ABC of heart failure: clinical features and complications.
(21.) Tan KT, Tayebjee MH, Lim HS, Lip GYH
. Clinically apparent atherosclerotic disease in diabetes is associated with an increase in platelet microparticle levels.